Barclays raised the firm’s price target on Medtronic (MDT) to $111 from $109 and keeps an Overweight rating on the shares. The firm upped estimates following the company’s organic growth “beat and raise” quarter.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MDT: